retatrutide schedule Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) Retatrutide Dosage: Week-by-Week Chart 2026

A simple weekly log works

Compounded medications are not FDA-approved products

And the company said all active pharmaceutical ingredients in compounded treatments are sourced exclusively from FDA-registered facilities, ensuring quality and safety

Abstract The high prevalence of obesity and diabetes will lead to higher rates of morbidity and mortality

Table of Contents Signs That Retatrutide May Be Working Key early signs include reduced appetite, gradual weight loss beginning within four to eight weeks, and improved fasting blood glucose or HbA1c in people with type 2 diabetes or insulin resistance

Increased Satiety Signals: By enhancing the body's natural fullness or satiety signals, GLP-1 medications can contribute to feeling full more quickly and for a longer time following a meal